ADMA Biologics, Inc. (ADMA)

ADMA Biologics, Inc. (ADMA) is a healthcare company (biotechnology) based in the United States. The share price is $13.27, down 1.48% on the day, which values the company at $2.94B. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$13.27−1.48% today
Market value
$2.94B
P/E ratio
17.2×last 12 months
Forward P/E
14.2×
Funk Score
72/100
Against its own history
About its usual priceusual price $12.22
200-week average
$11.4016% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

ADMA Biologics, Inc. in more detail

ADMA trades at 17.2× its last twelve months' earnings, 14.2× next year's expected earnings, 5.7× sales. Measured against its own history, the price is 9% above what its usual multiples would imply ($12.22) — about its usual price. It sits 16% above its 200-week average of $11.40.

Over the last five fiscal years ADMA Biologics, Inc. has compounded revenue 64.6% a year. Its Funk Score is 72 out of 100 (financial strength 8.9, profitability 6.9, growth 10.0, value 2.9, each out of 10).

In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Beneish M-score flags the accounts; Share count keeps rising.

2 of the superinvestors tracked here hold ADMA, including Stanley Druckenmiller (0.5% of the portfolio), Terry Smith (0.1% of the portfolio).

Superinvestors holding ADMA

2 of the investors tracked here report a position in their latest 13F filing.

ADMA Biologics, Inc. (ADMA): questions and answers

What is ADMA's P/E ratio?

ADMA Biologics, Inc. trades at 17.2× its last twelve months' earnings and 14.2× next year's expected earnings.

What is ADMA Biologics, Inc.'s market cap?

ADMA Biologics, Inc. is valued at $2.94B at a share price of $13.27.

Is ADMA overvalued or undervalued?

Against its own history, ADMA is about its usual price: the price is 9% above the $12.22 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ADMA above its 200-week moving average?

Yes. ADMA is 16.4% above its 200-week average of $11.40. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is ADMA Biologics, Inc. growing?

Over the last five fiscal years ADMA Biologics, Inc.'s revenue grew 64.6% a year; over ten years revenue grew 53.2% a year.

Does ADMA pay a dividend?

ADMA Biologics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “ADMA Biologics, Inc. (ADMA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ADMA

Underlying data: Yahoo Finance; company filings with the SEC.